FDA, NIH Devise Regulatory Research Agenda, Look For Financing
This article was originally published in The Gray Sheet
Executive Summary
The sequester is making it difficult to fund new projects, “no matter how high a priority,” National Center for Advancing Translational Sciences Director Christopher Austin noted during a June 25 teleconference to discuss Institute of Medicine recommendations for strengthening the Clinical and Translational Science Awards program.